BC Partners buys drugs maker Aenova from Bridgepoint
FRANKFURT, Aug 6 (Reuters) - Private equity group BC Partners has agreed to buy German vitamins and generic prescription drugs maker Aenova from Bridgepoint , the investors said in a joint statement on Monday.
Original Article: BC Partners buys drugs maker Aenova from Bridgepoint
NEXT ARTICLE